On January 2, 2018 BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, reported that management will provide a corporate update at the 2019 Biotech Showcase in San Francisco, California (Press release, BioLineRx, JAN 2, 2019, View Source;p=irol-newsArticle&ID=2381844 [SID1234532344]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2019 Biotech Showcase Presentation Details:

Date: Monday, January 7, 2019

Time: 4:00 p.m. Pacific Time

Webcast: Link to webcast information

The Company will also host institutional investor and partnering meetings at the 8th Annual LifeSci Advisors Corporate Access Event taking place in San Francisco, January 7-9, 2019.

To schedule a meeting with BioLineRx, investors can register on the online system managed by the Company’s US investor relations firm, LifeSci Advisors, LLC, or make a request via e-mail at [email protected].